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Abstract
Background: The poor face geographical, socio-cultural and health system barriers in accessing tuberculosis care.
These may cause delays to timely diagnosis and treatment resulting in more advanced disease and continued
transmission of TB. By addressing barriers and reasons for delay, costs incurred by TB patients can be effectively
reduced. A Tool to Estimate Patients’ Costs has been developed. It can assist TB control programs in assessing such
barriers. This study presents the Tool and results of its pilot in Kenya.
Methods: The Tool was adapted to the local setting, translated into Kiswahili and pretested. Nine public health
facilities in two districts in Eastern Province were purposively sampled. Responses gathered from TB patients above
15 years of age with at least one month of treatment completed and signed informed consent were double
entered and analyzed. Follow-up interviews with key informants on district and national level were conducted to
assess the impact of the pilot and to explore potential interventions.
Results: A total of 208 patients were interviewed in September 2008. TB patients in both districts have a
substantial burden of direct (out of pocket; USD 55.8) and indirect (opportunity; USD 294.2) costs due to TB.
Inability to work is a major cause of increased poverty. Results confirm a ‘medical poverty trap’ situation in the two
districts: expenditures increased while incomes decreased. Subsequently, TB treatment services were decentralized
to fifteen more facilities and other health programs were approached for nutritional support of TB patients and
sputum sample transport. On the national level, a TB and poverty sub-committee was convened to develop a
comprehensive pro-poor approach.
Conclusions: The Tool to Estimate Patients’ Costs proved to be a valuable instrument to assess the costs incurred
by TB patients, socioeconomic situations, health-seeking behavior patterns, concurrent illnesses such as HIV, and
social and gender-related impacts. The Tool helps to identify and tackle bottlenecks in access to TB care, especially
for the poor. Reducing delays in diagnosis, decentralization of services, fully integrated TB/HIV care and expansion
of health insurance coverage would alleviate patients’ economic constraints due to TB.
Background
The association between tuberculosis (TB) and poverty
has been well established [1-6]. The economically vul-
nerable are more likely to be exposed to conditions that
predispose to infection with mycobacterium tuberculosis
[3,7-11] and that propagate progression to disease
[5,11,12].
The poor face geographical, economic and health sys-
tem barriers to accessing care [5,13] which cause delays
in seeking healthcare [14,15] resulting in more advanced
disease and continued transmission of TB in the com-
munity. TB affects the most economically-productive
age, posing a significant economic burden on affected
households [3,16,17].
The three main types of economic constraints that TB
patients face are 1) charges for health services, 2) costs
for transport, accommodation and nutrition and 3) lost
income, productivity and time [5,18-21]. Direct (out-of-
pocket) costs for public or private services and indirect
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poverty for many families. This situation has been
termed ‘the medical poverty trap’ [22].
By addressing economic barriers and reasons for delay
to timely diagnosis and treatment, costs incurred by TB
patients can be effectively reduced. A number of studies
on patient costs have been published [1,13-16,18,20,
21,23,24], however there was a need to address some of
the methodological bottlenecks to assess barriers identi-
fied in these studies and make the Tool (including the
questionnaire, guidelines, data entry template) available
for national TB programs and other organizations work-
ing with TB. A consortium of partners (KNCV Tubercu-
losis Foundation, Japan Anti-Tuberculosis Association,
World Health Organization Stop TB department and
members of the Stop TB Partnership’sT B&P o v e r t y
Subgroup) therefore developed a Tool to assist TB con-
trol programs in assessing such barriers, funded by the
Tuberculosis Control Assistance Program (TB CAP/
USAID). It can be used worldwide and is not limited to
research organizations. The objective is to establish an
evidence base upon which interventions can be
designed.
A literature review on studies dealing with patients’
costs and methodologies employed was conducted to
determine at what stage patients are likely to incur which
kinds of costs. The findings of the review formed the
basis and context for the development of the Tool. The
generic Tool is designed to assess direct (out of pocket)
and indirect (opportunity) costs incurred by TB patients
at two distinct phases: 1) before and during diagnosis and
2) during treatment. The Tool also includes questions on
TB patient information; previous TB treatment episodes;
health-seeking behavior and delays; costs to the guar-
dian/treatment supporter of the patient; health facility
visit costs; social impact of the disease on the family
including children; and the impact of TB on food expen-
ditures and the welfare of the household.
The Tool contains an introduction, a literature review
on patient cost studies, a generic questionnaire to be
adapted to local circumstances, a brief review of socioe-
conomic indicators, a list of indicators to be measured
by the Tool, guidelines on the adaptation of the ques-
tionnaire to local circumstances, methods, sampling and
training of interviewers, on interpretation of results gen-
erated by the questionnaire, and on possible interven-
tions. An Epi Info template for data entry and an Excel
template to summarize results have been added to facili-
tate data analysis. The Tool can be downloaded for free
on the websites of the Tuberculosis Coalition for Tech-
nical Assistance (TBCTA; http://www.tbcta.org/Library/)
and Stop TB Partnership TB & Poverty Subgroup
(http://www.stoptb.org/wg/dots_expansion/tbandpov-
erty/spotlight.asp), see additional file 1.
The Tool was piloted in Kenya where TB diagnosis
(sputum smear microscopy) and treatment at public
health facilities are free of charge. The Kenyan national
tuberculosis control program (Division of TB, Leprosy
and Lung Disease DLTLD) follows the internationally-
recommended DOTS approach, promoted by WHO
since 2006 [25] with sputum smear microscopy as pri-
mary diagnostic tool for TB. Under DOTS, TB patients
require a treatment supporter to ensure and document
that the treatment has been followed continuously. The
procedure followed by TB patients is summarized in
figure 1. From a patient perspective, figure 1 shows a
simplified process; between illness and diagnosis there
are often many different care-seeking episodes. This
paper presents the results from this pilot.
Methods
Study sites
Kitui North and Mutomo districts, both in Eastern Pro-
vince, were purposively selected in consultation with
DLTLD, considering proximity to Nairobi and level of
socioeconomic development [26]. While 75% of incomes
stem from agriculture, this area is prone to persistent
droughts and crop failures resulting in food and income
insecurity [27].
Nine out of 41 health facilities offering TB services in
the pilot districts were purposively selected as pilot sites
based on caseload and accessibility (table 1); seven were
public health facilities and two were faith-based clinics.
Private facilities charging fees for service were not
selected with the focus of the pilot on the public sector.
The target enrolment was 200 patients for a sample size
sufficient to accurately evaluate the Tool and ensure suf-
ficient power of the analysis. Interview quotas based on
currently registered cases per facility as a proportion of
district caseloads were assigned to each of the nine
facilities.
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Kenyan TB program has changed its treatment regimen from an
eight-month to a six-month regimen. Retreatment cases receive an
eight-month regimen. Abbreviations: AFB: Acid-Fast Bacili; PTB:
Pulmonary Tuberculosis; EPTB: Extra-Pulmonary Tuberculosis.
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Every patient or treatment supporter representing a
patient (guardian) at the selected health facility who ful-
filled the in- and exclusion criteria as listed below was
eligible and asked to participate. Interviews were con-
ducted during TB clinic days.
Inclusion criteria
Patients (or guardians who came in place of patients)
who:
- Were new or re-treatment patients
- Had received at least (≥) 1 month of treatment for
TB (for their current diagnosis)
- Were at least (≥) 15 years of age
Exclusion criteria
- Currently hospitalized patients
- Patients under (<) the age of 15 years
All eligible patients were approached to enroll in the
study. All patients who accepted to sign an Informed
Consent form after being briefed on their rights as inter-
viewees were enrolled in the study.
Development of the questionnaire
The generic questionnaire of the Tool was adapted to
the local setting in consultation with central program
and local district staff. The questionnaire was pretested
at one of the sites where four patients were interviewed,
and adjustments were made as appropriate. The ques-
tionnaire was translated into Kiswahili and back trans-
lated into English to ensure accuracy of the translation.
During extensive discussion with central and district
staff, a decision was reached to ask patients about their
HIV status. Six interviewers were selected and trained.
All interviewers were Kiswahili speakers, and four were
native Kamba speakers, the dominant local language.
Interviews were conducted primarily in Kiswahili, with
Kamba in prompting questions. The research protocol
and standard operating procedure manual were
approved by the Scientific Steering Committee of the
Kenya Medical Research Institute (KEMRI).
Data entry and analysis
Responses gathered from patients were entered into Epi
Info 6.0, using double entry to enhance data quality.
Consistency and range checks were used to ensure com-
pleteness of data.
For the pilot in Kenya, direct costs incurred during TB
treatment were calculated per drug collection visit.
Direct costs are quantifiable, out-of-pocket costs asso-
ciated with TB: health care costs such as tests, adminis-
trative charges and medicines taken for TB symptoms
prior to receiving a TB diagnosis; transport costs to and
from health facilities; and associated food and accom-
modation costs. Any reimbursements received by
patients through insurance were deducted. Costs were
noted in Kenyan Shillings (KSH). The exchange rate was
65 KSH to one U.S. dollar.
Indirect costs were calculated as income lost due to
TB. For income lost prior to treatment, the time off
work was multiplied by the median reported individual
income prior to the onset of TB. For income lost during
treatment, the time off work was multiplied by the med-
ian reported individual income since the onset of TB.
Data was analyzed using Epi Info 6.0, Excel 2003 and
STATA 9.0 (STATA, Statacorp, Texas, USA). The Sha-
piro-Wilk test was used to test for normality. Due to
lack of normality in the quantitative data, non-para-
metric tests were used in the analysis. Wilcoxon
matched pairs signed ranks test was used when it was
not appropriate to use the paired comparison t-test. The
Kruskal-Wallis test was used to test the equality of inde-
pendent variables with two or more levels and an ordi-
nal dependent variable. In the analysis of categorical
variables, Fisher’s exact test was used to test for associa-
tion where the cell count was less than 5. Unless other-
wise specified, median values were used as a measure of
central tendency while inter-quartile range (IQR) was
Table 1 Information on pilot districts, 2008
Kenya Pilot District
Kitui North
Pilot District
Mutomo
Estimated population 38,277,856 473,241 291,576
Annual per capita income 2005 (KSH) [26] 35,480 10,699 n/a
Adult Literacy Rate, 2005 (%) [26] 68.7 69.9 n/a
TB cases (all types) notified in 2008 110,251 1,432 408
TB case notification rate/100.000 population 338 303 140
Estimated HIV prevalence in general population (%) 7.1 [36] 14 [27] 14 [27]
Number of public health facilities 6,696 [37] 74 17
TB treatment centers 2,228 41 12
TB treatment centers/100.000 population 6 9 4
(all data except where otherwise indicated [38]).
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level of statistical significance, according to the calcu-
lated sample size, was p = 0.05 with a confidence level
of 95%.
Due to known unreliability of income data [18,28-33],
household food expenditures and assets, partly based on
the Kenya Demographic and Health Survey 2003 [34],
were analyzed as proxies for income in addition to self-
reported individual and household income. All respon-
dents were assigned to five income groups to reflect
socioeconomic strata in the study districts. The groups
were determined jointly by study investigators and dis-
trict-level TB program staff.
Six months after the pilot, follow-up interviews with
key informants in the districts and at national level were
conducted to assess the impact of the pilot and to
explore potential interventions based on the findings.
Results
A total of 208 patients were interviewed. No patients or
guardians refused or stopped the interview.
The majority of interviews (n = 188) took place in
Kitui North, with 20 interviews in Mutomo. Nineteen
guardians/treatment supporters were interviewed (9%).
Differences in responses between guardians and patients
w e r en o to b s e r v e d .T a b l e s2a n d3a n df i g u r e2p r o v i d e
an overview on socioeconomic and TB-related informa-
tion for the sample population. 59% of the study popula-
tion was male with the majority between 26 and 40
years of age. 90% were new TB cases. 51% of primary
household income earners had only primary education.
Health seeking behaviour
Seventy-five percent of all patients reported accessing a
public health facility first. The remaining 25% visited a
private clinic or laboratory, and cited waiting times
(51%) and distance to the facility (30%) as reasons
behind their choice of facility. Only one patient visited a
tradtional healer. The median delay between the onset
Table 2 Sample population characteristics
Gender (unknown: n = 2) % (n)
Male 59 (121)
Female 41 (85)
Age (unknown: n = 2) % (n)
≤ 25 21 (43)
26 - 40 51 (105)
>40 28 (58)
Household size (unknown: n = 2) % (n)
< 3 10 (21)
3 to 5 44 (91)
> 5 46 (94)
TB Type (unknown: n = 2) % (n)
PTB SS+ 53 (109)
PTB SS- 39 (80)
EPTB 8 (17)
TB treatment category; HIV % (n)
New cases 90 (187)
Retreatment cases 10 (21)
HIV positive 33 (69)
Table 3 Socioeconomic information of sample population
Education of primary household income earner
(unknown: n = 2) % (n)
Primary school 51 (105)
Secondary school 32 (66)
Not attended 10 (21)
High school certificate 6 (12)
Adult learning 1(2)
Occupation (unknown: n = 2) % (n)
Small business 26 (54)
Casual labour 21 (43)
Housework 21 (43)
Subsistence farming 12 (25)
Civil servant 6 (12)
Transport, Student, Retired, Other 14 (29)
Drinking water source % (n)
Lake, pond, dam, river 46 (96)
Public well 6 (12)
Private well, bore hole 15 (32)
Piped water, bottled water 33 (68)
Type of toilet facility available % (n)
No facility, bush, field 5 (11)
Shared pit toilet, latrine 60 (124)
Own pit toilet, latrine 33 (68)
Flush toilet 2 (5)
Type of housing % (n)
Dirt floor, thatched roof 12 (26)
Dirt floor, metal roof 50 (104)
Concrete floor 38 (78)
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Figure 2 Household asset ownership at time of interview.
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Page 4 of 9of symptoms and seeking a diagnosis at a public facility
was 2 months (IQR 1-3 months).
Pre-diagnosis/diagnosis costs
Median direct costs incurred from the onset of TB
symptoms to diagnosis at a public health facility were
860 KSH (13 USD) per patient. This includes costs
related to visits to public, private or informal provi-
ders. A small number of patients had been hospitalised
before their current TB diagnosis was made (n = 12),
incurring disproportionately high costs: 2,177 KSH
(hospitalized, median) versus 832 KSH (not hospita-
lized, median).
Patients required a median of three health facility vis-
its, taking a median of 12 hours before receiving a diag-
nosis. In the pre-diagnosis phase travel to and from
health facilities and costs for diagnostic tests accounted
for most direct costs (38% and 37% of pre-diagnosis
direct costs respectively). Additional costs were food
purchased (lunch for health facility visits, vitamins; 19%)
and administrative charges at health facilities (6%).
Pre-diagnosis/diagnosis costs did not vary significantly
by age, gender or income level. However, patients with
extra-pulmonary TB (EPTB) experienced significantly
higher costs during the pre-diagnosis/diagnosis phase
mainly due to additional costs of xrays, reporting a med-
ian of 1,450 KSH compared to a median of 860 KSH for
patients of all other TB types (p = 0.0175).
Treatment costs
Patients had completed a median of 4 out of an
8 month treatment regimen at the time of the interview.
Costs due to DOT visits were not incurred, as all
patients interviewed received family DOT at home.
Direct costs during treatment consisted of travel costs
to collect drugs or for a follow-up sputum test (54%),
food (45%), accommodation, other tests, other drugs
and administration costs (together < 1%). Treatment
costs did not differ significantly by age, gender, income
level or TB type. The median total treatment cost was
105 KSH (1.6 USD; IQR 39-189 KSH) for each visit last-
ing a median of 3 hours each (IQR 2-4.5).
Coping costs
Most patients reported having to borrow money (57%)
and/or selling assets (52% of which 90% was livestock)
to cover the costs incurred. Patient income did not
determine whether or not they borrowed money. How-
ever, there was a relationship between patient income
and asset disposal (p = 0.03; c
2 = 10.53 with 4 d.f.),
with middle-income patients selling significantly more
than low- or high-income patients. Those who sold
assets gained significantly less than the market price
estimated by the patient (p = 0.000).
Indirect costs
Indirect costs for the entire duration of illness (19,123
KSH; 294 USD) constituted 85% of total costs. For the
pre-diagnosis phase, this was calculated using patients’
median monthly income before the illness (4,250 KSH),
multiplied by the median amount of time they were out
of work as a direct result of their illness (4.5 months, n
= 174). For the treatment phase, median monthly
patient income after the onset of TB (0 KSH implying
that patients have not resumed work) was multiplied by
the amount of time required for TB treatment over 14
drug collection visits (42 hours).
Total costs and change of income due to TB
Table 4 summarizes all incurred costs. The median total
of direct and indirect costs was 22,753 KSH (350 USD).
This was equivalent to 45% of median annual individual
incomes (50,960 KSH; 784 USD) and 27% of median
annual household incomes before TB illness (84,260
KSH; 1,296 USD). Both household and individual
incomes dropped due to TB (figures 3, 4). After the
onset of TB, total costs increased by 20%, to 47% of
median household incomes. Food and healthcare expen-
ditures increased from 46% to 223% of median monthly
household income.
Figure 5 shows the lowest income group reduced
expenditures on food items due to TB while higher
income groups tend to increase food expenditures due
to TB. Adequate nutrition is important during treatment
to make up for weight previously lost due to the illness.
In addition, anti-TB drugs can cause nausea and are
more easily digested after food intake.
HIV
33% of all patients interviewed reported to be HIV+.
Two percent declined to answer the question, 53% con-
firmed they were HIV-, 4% had not been tested and 8%
were unsure. Compared to HIV- patients, HIV+ patients
experienced 16% higher direct costs during the pre-diag-
nosis/diagnosis phase and 48% higher costs during treat-
ment, associated with collection of anti-retroviral drugs,
however not statistically significant.
Gender
Men and women did not report statistically significant
differences in costs. However, women were more likely
to have low incomes and thus devoted a higher percen-
tage of their income to TB-related costs (figure 6).
Reported patient delay did not differ significantly
between men and women.
Productivity and social impact of TB
Patients were asked to estimate the number of hours
they worked per week before and after the onset of TB.
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Page 5 of 9Of the 208 respondents, 85% reported a decrease as a
result of TB illness. 15% of those who worked fewer
hours had a family member take over their work, in 5%
of cases this was a child. However, no child stopped
school to undertake this work. Of all respondents, 9%
had children that completed school and worked to raise
money during the TB illness. 11% of respondents
employed someone to do the housework. A house help
earned a median of 2,000 KSH per month, which can be
used to assign a value to unpaid household work. 28%
of respondents reported disrupted social life due to TB,
affecting sexual life (n = 93); job loss (n = 20); divorce
(n = 5) and separation from spouse (n = 10).
Insurance
Twelve percent of patients reported having some form
of health insurance, with only one patient having inpati-
ent benefits. Higher-income patients were more likely to
have health insurance (p = 0.005). However only in one
case insurance covered outpatient costs.
Results of follow-up interviews
Six months after the presentation and discussion of the
Tool’s findings with program staff at national and dis-
trict level, follow-up interviews were conducted with key
informants (Kenyan TB experts and local staff involved
in the initial study). The objectives of these interviews
were to assess the impact of the pilot, the usefulness of
study findings and to explore the feasibility of recom-
mendations. Decentralization of treatment services and
HIV service integration were seen to be of greatest ben-
efit in tackling TB-related direct costs.
Discussion
Key findings
The implementation of the Tool to Estimate Patients’
C o s t ss h o w e dt h a tT Bp a t i e n t si nK i t u iN o r t ha n d
Mutomo have a substantial burden of direct and indirect
costs due to TB. The majority of costs are indirect (38%
of annual individual income before the disease). Inability
to work is a major cause of increased poverty and con-
tributes to worsening of individual economic situations.
The proportion of patients not earning a regular income
increased from 15% to 54% after the onset of disease.
Individual incomes dropped to zero after onset of TB
and household incomes dropped by 43%. Although less
than indirect costs, direct costs are still considerable (7%
of individual annual income) with transport as the big-
gest cost item. Results confirm a ‘medical poverty trap’
Table 4 Total Costs and Summary
Median Direct Costs KSH (IQR) USD % of median
annual individual
income (pre-TB)
Pre-Diagnosis/Diagnosis Costs 860 (500-1,670) 13.2 (8-26) 1.7
Treatment Costs (cost/visit × 14 visits) 1,470 (560-2,660) 22.6 (9-41) 2.9
Coping Costs 1,300 (800-2,500) 20 (12-38) 2.6
Sub-Total 3,630 55.8 7.1
Median Indirect Costs
Foregone income before diagnosis (4.5 months of
work lost × initial monthly income)
19,123 (6,750-40,500) 294.2 37.5
Foregone income during treatment: drug
collection time × current income. (Total drug
collection time = hours/visit × 14 visits)
42 hours × zero income = 0
Sub-Total 19,123 294.2 37.5
Median Total Costs
Direct + Indirect Costs 22,753 350 44.6
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Figure 3 Household monthly income groups before and after
onset of TB. Reported quintiles are those of the study population.
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Figure 4 Individual monthly income groups before and after
onset of TB.
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Page 6 of 9[22] situation in the two districts: expenditures increased
while incomes decreased.
Usefulness of the Tool
The information generated by the Tool can be used as
an evidence base for subsequent interventions to allevi-
ate the financial burden of TB patients. Reducing delays
in diagnosis, decentralization of services, integration of
TB/HIV care and inclusion of TB in- and outpatient
services in health insurance schemes while increasing
insurance coverage could alleviate economic constraints
due to TB [35]. Recommendations that were based on
the findings of the pilot and the follow up interviews
included: further decentralization of TB care, realign-
ment of the currently used communication strategy to
stimulate TB suspects to seek care early, mobile clinics,
stronger TB/HIV program coordination to allow for
integrated TB/HIV care, further usage of the Tool in
other areas.
Following the study, fifteen more facilities in the pilot
districts were equipped as TB treatment centres. The
district TB and Leprosy coordinators approached the
World Food Program to discuss nutritional support of
TB patients and local partners for sputum sample trans-
port to distant diagnostic centres to reduce patients’
transport costs and time spent on the road. On the
national level, a TB and poverty sub-committee was
convened to develop a comprehensive pro-poor
approach within the routine TB program.
Comparability of the Tool
TB costing studies done elsewhere in East Africa and
Asia show similar results (Table 5) in respect to direct
costs (Malawi) and indirect costs (India). Due to study
design differences, exact costs comparisons cannot be
made, the results are nonetheless informative.
Study limitations
Estimating monetary incomes was difficult for those
without regular salaries. Disaggregated costing questions
about everyday amounts would be more graspable. Ask-
ing the same questions at different times of the agricul-
tural year might yield different responses and it is
difficult to ensure that patients are reporting incomes,
not turnover from business. Furthermore, assigning a
monetary value to unpaid housework and health insur-
ance were difficult concepts to communicate. Patient
recall declined noticeably after four months on TB treat-
ment and time-sequence prompts were useful.
A weighted asset index was not made as it was beyond
the purpose of this study. Patients’ mobility was omitted,
hence migration patterns of TB patients were not
assessed. Questions relating gender and equitable access
were difficult to convey. More gender sensitization in
interviewer trainings may have been necessary. Report-
ing expenditures for food as done in this study is not
equal to food consumption. Therefore reduction in food
expenditure does not necessarily imply a reduction in
food consumption as households may produce their
own food or may receive food from others when in
need. Including local program staff as interviewers gave
12000
8000
10000
12000
n
g
s
4000
6000
8000
10000
12000
y
a
n
 
S
h
i
l
i
n
g
s
before
after
2000
4000
6000
8000
10000
12000
K
e
n
y
a
n
 
S
h
i
l
i
n
g
s
before
after
0
2000
4000
6000
8000
10000
12000
0 <5K 5-10K 10-20K >20K
K
e
n
y
a
n
 
S
h
i
l
i
n
g
s
IG
before
after
0
2000
4000
6000
8000
10000
12000
0 <5K 5-10K 10-20K >20K
K
e
n
y
a
n
 
S
h
i
l
i
n
g
s
Income Groups
before
after
0
2000
4000
6000
8000
10000
12000
0 <5K 5-10K 10-20K >20K
K
e
n
y
a
n
 
S
h
i
l
i
n
g
s
Income Groups
before
after
Figure 5 Monthly household food expenditures by income
group.
0
100
200
300
400
500
600
700
800
Direct Indirect Total
Median Costs Incurred
%
 
o
f
 
m
o
n
t
h
l
y
 
i
n
c
o
m
e
 

Male
Female
Figure 6 Total direct and indirect costs by gender as% of
monthly individual income.
Table 5 TB Patient Cost Study Comparison
Study Costs Incurred
(% of household annual
income)
Lost
Work
(months)
Direct
Costs
Indirect
Costs
Total
Costs
India (rural/urban) [17] 13 26 40 2.5
Zambia (rural/urban)
[21]
8.3 4.8 13.1 n/a
Thailand (rural/urban)
[16]
8.6 2.3 10.9 2.7
China (rural) [13] n/a n/a 45 n/a
Kitui (rural/urban) 4.3 22.7 27 4.5
Costs Incurred
(% of individual annual income)
Malawi (urban) [18] 5 6.3 11.5
Kitui (rural/urban) 7.1 37.7 44.8
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Page 7 of 9them an opportunity to speak with patients in-depth
and to conceptualize strengths and challenges of the TB
program. However, it is possi b l et h a tt h ep r e s e n c eo f
staff influenced the responses of patients.
In Mutomo only 20 patients could be interviewed.
This district was therefore relatively undersampled,
because 22% (n = 44) were targeted based on case num-
bers. Due to the small sample, an analysis for sensitivity
between the districts could not be done. However, sig-
nificant differences between Mutomo and Kitui North
are not expected as they used to be one district until
2008. Thus, a bias of study results is not presumed.
Sensitivity of income data was not analyzed in this
study. When comparing annual per capita income of the
Kenya Human Development Report [26] in 2005 (Kenya
35,480 KSH; Kitui North 10,699 KSH; 76 KSH per USD)
with our finding of median annual individual income of
50,960 KSH in 2008 (65 KSH per USD), it is likely that
self-reported income was over-estimated in this study. If
we assume an over-estimate of 43%, median annual
income before TB would be 523 USD instead of 748
USD; and median annual household income 906 USD
instead of 1296 USD. Total costs would constitute 67%
of annual individual income and 39% of annual house-
hold income which is 22% and 12% more than what our
findings indicate. Future studies and implementers of
this Tool are therefore advised to compare income
results to recent national demographic and health sur-
veys, data from the national statistics office or Human
Development Reports to put results into context. In
addition, food consumption and asset indices are recom-
mended as proxies for income. Despite challenges in
assessing income, the results of this study nevertheless
show a remarkable impact of TB on the welfare of
households and individuals.
Conclusion
The Tool to Estimate Patients’ Costs proved to be a
valuable instrument to assess patients’ costs, the socioe-
conomic situation of the patients, health-seeking beha-
vior, concurrent illnesses such as HIV, as well as social
and gender-related impacts. In addition, the Tool helps
to assess the economic impact of TB on individual and
household welfare and to identify bottlenecks in access
to TB care. The mere usage of the Tool can already
have an impact by involving staff who take responsibility
in improving the situation for TB suspects and patients.
Challenges such as recall bias and gender-related sensi-
tivities are difficult to address; each cultural setting will
need to find its best-suited approach. The improved
Tool has been subsequently implemented in the Domin-
ican Republic, Ghana and Viet Nam. Establishing evi-
dence on patients’ costs in different parts of the world
will be instrumental in advancing the calls for free TB
diagnosis, integration of TB/HIV services and compre-
hensive health and disability insurance for the poor.
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